X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
PFIZER LIMITED Quarterly Results - Equitymaster
 
PFIZER LIMITED   - Last 8 Quarters  (PFIZ)

Here are the latest quarterly results of Pfizer. For more details, see the Pfizer financial fact sheet and Pfizer share price and chart. For a sector overview, read our pharmaceuticals sector report.
 Interim Results
No. of Months
Qtr. Ending
3
Mar-15
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
8-Qtr Chart
Click to enlarge
Net Sales Rs m4,6314,8425,1215,0565,1515,0125,5775,102 
Other income Rs m188168162244284215243265 
Turnover Rs m4,8195,0105,2835,3005,4345,2285,8205,368 
Expenses Rs m3,3833,7253,8804,2363,9203,9223,6304,290 
Gross profit Rs m1,2481,1181,2418201,2301,0901,947812 
Depreciation Rs m336311296314318150161154 
Interest Rs m21121422 
Profit before tax Rs m1,0979741,1067471,1961,1522,027921 
Tax Rs m671436489344526351764297 
Profit after tax Rs m4275386164036708001,263624 
Gross profit margin %26.923.124.216.223.921.834.915.9 
Effective tax rate %61.144.744.246.044.030.537.732.3 
Net profit margin %9.211.112.08.013.016.022.712.2 
Diluted EPS Rs 9.3 11.8 13.5 8.8 14.6 17.5 27.6 13.6  
Diluted EPS (TTM) Rs 38.4 40.1 39.5 43.4 48.7 54.4 68.6 73.4  
 Subscriber Feature   Our View              
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster



Today's Market

Sensex Finishes Lower; Metal & FMCG Stocks Drag(Closing)

Share markets in India finished on a weak note as investors continued to book profits ahead of the April F&O expiry. At the closing bell, the BSE Sensex closed lower by 104 points.

Views on news

Sun Pharma: Slow Growth Across Major Markets (Quarterly Results Update - Detailed)

Mar 11, 2017

Sun Pharma has announced its December quarter (3QFY17) results. The company has reported 8% YoY growth in sales and a decline of 4.7% YoY in the net profits.

Cipla: Operating Margins Improve (Quarterly Results Update - Detailed)

Mar 8, 2017

Cipla has announced its results for the December quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Glenmark: Zetia Generics Boost Growth (Quarterly Results Update - Detailed)

Feb 15, 2017

Glenmark has announced its 3QFY16 results. The company has reported 41% YoY growth in net sales and 143.2% YoY increase in net profits. Here is our analysis of the results.

Sun Pharma: USFDA Observations Post Good Quarterly Performance (Quarterly Results Update - Detailed)

Dec 12, 2016

Sun Pharma has announced its September quarter (2QFY17) results. The company has reported 13.2% YoY growth in sales and a growth of 117% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Our Private Class with India's Value Investing Guru(The 5 Minute Wrapup)

Apr 19, 2017

Rohan and Kunal present you the discussions with professor Sanjay Bakshi in his virtual classroom.

HDFC Bank: The Solid Outperformer(Chart Of The Day)

Apr 22, 2017

Why HDFC Bank beat the Sensex by nearly 3 times.

The Real Reason Indiabulls Real Estate Jumped 42%(Daily Profit Hunter)

Apr 19, 2017

An elephant and six blind men will tell you more about the markets than any financial newspaper or channel.

In an Ocean of Corporate Defaulters, Vijay Mallya is a Small Fish(Vivek Kaul's Diary)

Apr 20, 2017

While it is important to get Mallya back to India, the government needs to show the same vigour in chasing defaulters of public sector bank loans residing in India.

4 Ways GST Will Impact The Mutual Fund Industry(Outside View)

Apr 19, 2017

PersonalFN explains how GST would impact India's mutual fund industry and investors

More

PFIZER SHARE PRICE


Apr 27, 2017 (Close)

TRACK PFIZER

MORE ON PFIZER

PFIZER - ELDER PHARMA COMPARISON

Compare Company With Charts

COMPARE PFIZER WITH

MARKET STATS